Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 3037 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
 


 

 
     
    Advanced search
 

 
 
  
    Similar in PUBMED
    Email Alert *
    Add to My List *
* Registration required (free)  


   Introduction
    Overview of Asse...
    Diagnosing Intel...
    Laboratory Inves...
    Psychosocial Ass...
    Disability Asses...
    Formulating a Tr...
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed1084    
    Printed9    
    Emailed0    
    PDF Downloaded342    
    Comments [Add]    

Recommend this journal

 


 
 Table of Contents    
CLINICAL PRACTICE GUIDELINES  
Year : 2019  |  Volume : 61  |  Issue : 8  |  Page : 194-210
Clinical practice guidelines for assessment and management of intellectual disability


1 Clinical Psychology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India
2 Human Genetics, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India
3 Child and Adolescent Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India

Click here for correspondence address and email

Date of Web Publication14-Jan-2019
 

How to cite this article:
Kishore M T, Udipi GA, Seshadri SP. Clinical practice guidelines for assessment and management of intellectual disability. Indian J Psychiatry 2019;61, Suppl S2:194-210

How to cite this URL:
Kishore M T, Udipi GA, Seshadri SP. Clinical practice guidelines for assessment and management of intellectual disability. Indian J Psychiatry [serial online] 2019 [cited 2019 Aug 22];61, Suppl S2:194-210. Available from: http://www.indianjpsychiatry.org/text.asp?2019/61/8/194/250038





   Introduction Top


Mental retardation is a developmental disorder and is associated with significant limitations in intellectual functioning and adaptive behaviors. Currently, it is widely referred to as “intellectual disability (ID)” and “intellectual developmental disorders (IDDs).” In India, the Rights of Persons with Disabilities Act (2016) has introduced the term “intellectual disability” in the place of “mental retardation.” However, India being a signatory country to the World Health Organization (WHO), where the International Classification of Diseases, 10th revision (ICD-10) guidelines are adopted in the clinical practice, the term “mental retardation” is still in clinical use (The WHO Working Group on the Classification of Intellectual Disabilities has recommended replacing the term “mental retardation” with “IDD” in ICD-11 (Salvador-Carulla et al., 2011). Thus, both the terms, intellectual disability and mental retardation, are in use in India. Despite variation in the terminology and the differences in the criteria for diagnosis (e.g., ICD-10; Diagnostic and Statistical Manual of Mental Disorders, 5th Edition [DSM-5]) and assessment of disability (as notified in the guidelines in January 2018, which are based on the RPD Act), it is commonly agreed that significant impairments in intellectual functioning and adaptive behavior during the developmental period is the hallmark of the condition [Table 1].
Table 1: Terminology and conceptual issues related to intellectual disability among different diagnostic systems

Click here to view


It is estimated that nearly 2.5% of the global population will have low levels of intellectual functioning commensurate with ID. However, a wide variation in point prevalence of ID has been reported in India, from around 1/1000 to 32/1000, depending on the case definition, methodology, and population selected. An important point that can be noted in the literature is that prevalence rates vary depending on whether deficits in either intellectual functioning or adaptive behavior or both are considered. Although ID is recognizable in infancy or early childhood, it is often difficult to accurately diagnose it before 5 years of age. Hence, global developmental delay (GDD), which often predicts future development of ID, is used as a surrogate marker in children between the age group of 3 months and 5 years. Shevell et al. (2008) defined GDD as evidence of significant delay in two or more of the following developmental domains: gross/fine motor, speech/language, social/personal, cognition, and activities of daily living. However, not all cases of GDD may have cognitive deficits or end up as ID. Males are diagnosed with ID 30% more than females, especially in the milder ID range. However, this difference seems to disappear when the ID is more severe. ID is also associated with high morbidity and extreme costs of care. ID can cause significant impact on the individual, families, health-care system, and state.

Nature and needs of the condition

ID is a permanent condition therefore it creates special needs for both the individual and the family across the life span. The needs could be related to independent mobility, physical care, communication needs, modified curricula, aids and appliances, occupational and vocational opportunities, and medication if there are treatable, comorbid medical conditions. The special needs may necessitate support in varying degrees throughout the life span. Therefore, holistic programs should address the lifelong needs in a step-by-step fashion. For instance, when a child with ID is in preschool years, the needs may center around self-care, sociocommunication skills, and school readiness skills but not so much about independent living or literacy. Similarly, for an adolescent with ID, the needs could be about education, prevocational training, and future independent living. As these examples indicate, ID will imply long-term, multidisciplinary approach to intervention for optimum outcome.

Etiological workup of intellectual disability

The etiology of ID/GDD is heterogeneous. The cause for ID and GDD can be nongenetic/environmental or genetic. Nongenetic causes such as prenatal infections, substance use like alcohol intake during pregnancy, and postnatal meningoencephalitis account for only one-third of cases and the rest are of genetic origin. The flowchart in [Figure 1] is a modified version of the “Finnish approach.” This provides a means for systematic etiological evaluation of ID. The common causes are also listed in the flowchart [Figure 1].
Figure 1: Finnish approach

Click here to view


This modification of the Finnish approach at the preliminary level reliably distinguishes probable genetic and nongenetic etiologies in a majority of cases. Most of the nongenetic causes produce ID which is usually static in nature and potentially amenable for training. Further, the nongenetic causes in the subsequent pregnancies are either treatable or preventable, especially the maternal factors such as malnutrition, diabetes, teratogenic drugs, and substance use. The Finnish approach also paves way for further diagnostic and genetic testing among those cases initially suspected to be of genetic etiology. Genetic diagnosis is essential not only for accurate genetic counseling of recurrence risks and prenatal diagnosis, but also for appropriate management. This is in the light of newer strategies of treatment made available through thorough understanding of the pathophysiology of genetic disorders for several disorders. With the advances in the field of therapeutics, over eighty potentially treatable disorders have been identified. Majority of such inherited cases can be accurately diagnosed, provided that advances in the field of genetic diagnostics are utilized.

Comorbidities

Medical comorbidities

Various medical comorbidities are often associated with ID. Depending on the etiology, varying degrees of both neurological and nonneurological comorbidities are encountered. Some are a consequence of ID itself. Few of the common medical comorbidities are the following: epilepsy, spasticity, dystonia, ataxia, visual impairment, hearing impairment, congenital heart disease, cleft lip and cleft palate, limb anomalies such as congenital talipes equinovarus, congenital dislocation of hip joint, renal malformations, failure to thrive with vitamin and mineral deficiencies, recurrent infections, feeding disorder, and short stature.

Epilepsy is a common comorbidity with a prevalence of nearly 15%–30%. With increasing severity of ID, the prevalence increases to around 50%. Similarly, many electroclinical syndromes of epilepsies such as early infantile epileptic encephalopathies, West syndrome, and Ohtahara syndrome as well as other late-onset syndromes such as Lennox–Gastaut syndrome are invariably associated with ID. Ongoing seizures, especially if treatment refractory, often lead to developmental arrest. Such a condition remains a barrier against training and thereby against any hope of making developmental gains. Hence, it is essential that these disorders need particular attention and rigorous management.

Another domain of neurological disorder that impairs motor development and locomotion is the impairment in pyramidal, extrapyramidal, or cerebellar systems as well as combined. Spasticity, dystonia, tremors, and ataxia often lead to impairment in motor development and thereby successful locomotion. It is essential to differentiate the static or progressive forms of these disorders for appropriate counseling and management.

The medical comorbidities can be significant barriers for training and developmental learning and require attention in overall management. One can anticipate almost certainly the possibilities of physical disorders based on the etiology behind ID. With vast literature available on almost every one of the etiologies, we can predict and screen for the presence or absence of the comorbid medical disorders.

Behavioral and psychiatric problems

People with ID are 3–5 times at higher risk of any psychiatric disorder compared to the general population at all ages, with a cumulative prevalence of around 40%. It is conceivable that global cerebral functioning is affected by varying etiologies causing ID, which in turn can lead to a variety of neuropsychiatric manifestations. Besides these neurobiological underpinnings, social discrimination and deprivation can also influence the onset of psychiatric comorbidities in this group. Neuropsychiatric manifestations often commence insidiously with atypical presentation and are commonly written off as spectrum manifestations of ID. Hence, it is mostly underreported, misdiagnosed, and undertreated. This pattern of “diagnostic overshadowing and masking” is well documented. Limited choice in using structured diagnostic interviews is another barrier for accurate diagnosis of comorbid psychiatric condition. Eventually, only symptomatic treatment is resorted to, which may not solve the entire problems. Therefore, special efforts are required to identify behavioural and psychiatric disorders.

The etiology of ID can often provide clues to anticipate certain psychiatric comorbidities as certain behavioral phenotypes are frequently associated with some syndromes. Some examples are severe self-injurious behavior in Lesch–Nyhan syndrome; skin picking and obsessive-compulsive disorder in Prader–Willi syndrome; autistic traits and hyperactivity in Fragile X syndrome; self-hugging stereotypy and trichotillomania in Smith–Magenis syndrome; schizophrenia-like disorders in 22q11 deletion syndrome. In majority, unspecified behavioral disorders are very common.


   Overview of Assessments and Evaluation Top


Assessment is a process of collecting data for the purpose of making decisions. Assessment provides us with baseline information for intervention, whereas the evaluation is the assessment of outcome of an intervention. In clinical practice, therefore, we need both assessment and evaluation methods. The purpose of the assessment is as follows:

  1. To identify the condition based on specific criteria and to establish that it is a clinical entity that requires appropriate mental health services and placement decisions
  2. To identify and treat etiological factors and risk factors for ID
  3. To identify the needs implicated by the condition and design a program plan to reduce the disability impact
  4. To match the nature and needs of the conditions effectively with the best intervention methods available
  5. To evaluate the effectiveness of intervention.


The following key questions could be asked to guide assessment, intervention, and outcome measure [Please see [Appendix 1] for more details]:



  • What is the nature of the delay – specific or global?
  • Is the delay associated with significant limitations in intellectual functioning and adaptive behavior?
  • Are there any comorbidities?
  • Are there any treatable etiological conditions?
  • What are the areas of intervention?
  • Where and how the intervention should be carried out?
  • Where the individual should be placed for maximum help (or, what are the existing agencies/service providers through which the interventions can be implemented)?
  • How to evaluate the intervention outcome (or, what are the indices to stop intervening)?



   Diagnosing Intellectual Diasbility and its Comorbidities Top


The diagnostic process of ID is similar to any other behavioral and mental disorders but with subtle differences. The diagnostic process involves history taking, observation including medical examination, intellectual and adaptive behavioral assessment, identification of comorbid psychiatric disorders, and need-based laboratory investigations for other medical conditions. Therefore, the diagnostic process encompasses several components that are described as follows:

History taking

The purpose of eliciting the history is to establish that there is an evidence for deficits in both intellectual functioning and adaptive behaviors that have an onset during the developmental period, to note possible etiology of ID, and to identify comorbidities and response to interventions, if any. Therefore, it requires interviewing of key people including the index patient and behavioral observation of the patient. Key people could be parents, caregivers, and service providers who know the birth and developmental history of the child.

A useful and comprehensive approach to assessment would include noting chief complaints in chronological order with mode of onset, duration, and precipitating event followed by a history of presenting illness and a detailed prenatal and perinatal history as a prelude. Developmental history in greater detail, particularly related to motor, language, and communication; self-help skills; socioemotional skills; cognition; and occupational skills/leisure-time activities; medical comorbidities and its treatments; psychiatric history including the details of onset, evolution, and current status of behavioral and other psychopathological disturbances; and treatment history. This should be followed by a comprehensive family history including the three- generation pedigree; consanguinity; family background; current living arrangements; and details of potential stressors, coping, and adaptation by the family.

Physical examination

It must involve routine systemic examination, anthropometric assessment, and observation of atypical morphological features suggestive of specific genetic disorders. Detailed physical examination helps to identify the etiology in a majority of cases, detect comorbid medical conditions, and also order appropriate investigations. Physical examination in cases with ID consists of three parts which are as follows:

Anthropometry

This provides indication toward nutritional status and underlying medical or genetic condition. The measures should include the following: height (length in case of neonates and infants), arm span, upper segment and lower segment lengths, sitting height, weight, head circumference, chest circumference, abdominal circumference, intercanthal and interpupillary distances, and palm and foot lengths.

Dysmorphology examination

Dysmorphology is the observation, documentation, and study of birth defects as well as syndromes. A thorough head-to-toe examination should be carried out to identify minor physical anomalies (MPAs), which provide clues toward etiological diagnosis, especially the genetic disorders [Table 2]. It requires keen observation and knowledge of normal versus abnormal morphology.
Table 2: Some common minor physical anomalies and other findings on physical examination

Click here to view


Examination of major organ systems

A systematic examination of all the organ systems to rule out multiorgan involvement and comorbid medical conditions has to be performed for overall assessment and management. It is essential to be meticulous in observing and documenting the findings of physical examination as many of the MPAs can be easily missed. Hence, it may be important to take photographs or videos after informed consenting to document and revise the original findings at a later date. Some of the essential things to note are vision, hearing, locomotion (videos may help), and any major congenital anomalies. The presence of MPAs provides clues toward genetic versus nongenetic etiologies [Table 2]. Hence, branding every child universally with cerebral palsy which is often due to a nongenetic cause with a static course can be avoided. Presence of four or more MPAs should alert the physician toward probable genetic cause.

If MPAs are encountered in a child, such a case can be referred to a dysmorphologist/medical geneticist for further evaluation (the following are excellent sources for syndromes and standard terminology and definitions of MPAs – Smith's Recognizable Patterns of Human Malformations and “Elements of Morphology” in American Journal of Medical Genetics, 2009 [available from https://onlinelibrary.wiley.com/toc/15524833/149A/1]).

Further, progressive multiorgan dysfunction may be a clue toward a disorder of inborn error of metabolism which may be potentially treatable. Organ system examination is similar to any branch in medicine, and clinicians can refer to standard books like Hutchison's Clinical Methods.

Behavioral observation

The purpose of behavioral observation is to corroborate the clinical history with regard to intellectual functioning and behavioral repertoire. Therefore, it should start with observation of general appearance, any oddities in behavior, attention span, receptive and expressive speech abilities, and social and interpersonal abilities. Socioculturally appropriate stimuli could be presented to understand the level of general fund of knowledge, generic concepts, abstract thinking, reasoning, and problem-solving abilities that are not strictly dependent on academic learning. However, clinicians may use any standard format of general mental status examination for children to complement the behavioral observation.

Assessment of intellectual functioning and adaptive behavior

This step is to confirm the clinical diagnosis and identify the severity level of ID. Both ICD-10 and DSM-5 recognize the need for assessing the intellectual functioning with standardized tools that yield intelligence quotients (IQs). DSM-5 restricts the use of IQ to draw a cutoff of 65–75 (IQ 70± standard error of 5) for identifying ID. Conversely, ICD-10 advocates a IQ cutoff of 70 to identify ID and different IQ ranges for categorizing four severity levels such as, mild (IQ: 50–69), moderate (IQ: 35–49), severe (IQ: 20–34), and profound (IQ <20). The ICD-11 Working Group advocated that severity levels for IDD should rely on a clinical description of the characteristics of each subcategory, but the IQ score can be considered as one of the clinical descriptors that are important in determining the severity level. Therefore, till the time ICD-11 comes into force, the ICD-10 guidelines should be followed, which rely on IQ both for identifying the condition and ascertaining the severity levels of ID.

Clinicians may note that the choice of tests in the Indian context is limited notwithstanding the fact that the norms are in many cases are not revised [Appendix 2]. This is a major concern given the evidence for Flynn effect, which refers to observed rise in IQ scores over time and related norm obsolescence. Therefore, the IQ scores should not be rigidly interpreted.



When IQ tests are not applicable because of young age (e.g., children below 3 years) or associated sensory-motor issues and gross understimulation, standardized developmental scales (e.g., Developmental Screening Test and Developmental Assessment Scales for Indian Infants) can be used as applicable. The developmental tests yield “developmental quotients” which are interpreted in the same way as IQ scores.

With regard to the assessment of adaptive behavior, Vineland Social Maturity Scale (VSMS) is the only standardized measure available in India at present. The VSMS yields social quotient (SQ) and a profile of eight important domains of adaptive behavior. If the administration of VSMS is not possible for any reason, clinicians can ask socioculturally relevant questions to understand the level of adaptive behavioral functioning. If needed, DSM-5 list of specifiers for severity levels of ID could be referred to assess the adaptive behaviors till the time ICD-11 guidelines come up.

Wherever IQ and SQ indicate different severity levels of ID, decisions are taken in favor of SQ scores because the latter denotes the degree to which the index patient is able to meet the standards of culture-appropriate demands of daily life. Thus, SQ reflects the severity of ID better than IQ under ordinary circumstances. However, when assessment of the severity of ID by means of the usual procedures is rendered particularly difficult or impossible by associated sensory or physical impairments and severe behavioral disturbances, the condition should be identified as “Other mental retardation.” If there is evidence of mental retardation, but insufficient information is available to assign the patient to one of the four categories or other mental retardation, it can be identified as “unspecified mental retardation.” In case of “Other mental retardation” and “unspecified mental retardation,” more information on developmental skill repertoire and periodical assessments of intellectual and adaptive behavior is desirable to infer the current level of functioning and associated severity levels of ID. Test selection should be proper if the person has comorbid sensory-motor impairments [Appendix 3]. Lastly, it must be recognized that the use of IQ and adaptive measures for clinical diagnosis is different from disability assessment and the latter has specific guidelines that must be strictly adhered to.



Confirmation of intellectual disability diagnosis

Based on the information obtained through case history, observation, and testing, ID could be coded into any of the six categories such as mild, moderate, severe, profound, other, and unspecified mental retardation. The ICD-10 has provision for using a fourth character to specify the extent of the behavioral impairment if this is not due to an associated disorder (e.g., F7x. 0 to denote “no, or minimal, impairment of behavior”) and an additional code from the ICD-10 should be used if the cause is known (e.g., F72 severe mental retardation plus E00. [congenital iodine-deficiency syndrome]). Evidence for additional coding of etiological causes may come from laboratory findings.

Diagnosis of comorbid psychiatric disorder

Any changes in behavior compared to previous period, dip in overall functioning, and changes in vegetative functioning should be carefully recorded in each visit. If it is pervasive and indicative of a comorbid psychiatric disorder, it has to be carefully considered. A timeline method would be helpful when in doubt. During clinical evaluation, a greater reliance on onset and chronological evolution of symptoms, intensity, frequency, context of occurrence of symptoms, and precipitating and relieving factors elicited through careful interviewing of parents and caregivers will help in uncovering the psychopathology. School report is a valuable additional source of information. A period of behavioral observation rather than just traditional psychiatric interview will often help the clinician to decide on the presence and type of psychiatric disorder.

The behavioral observation will start from the moment the child enters the consultation room. Equal attention needs to be paid to child's behaviors, parental reports, as well as to verbal interview in arriving at conclusions. If necessary, the child and its parents must be interviewed separately. Playroom observation and multiple baseline observations for a functional analysis (Antecedent-Behavior-Consequences analysis) of symptoms are sometimes required.

Clinicians may need to create child-friendly space with appropriate toys, picture books, and art and craft materials. The setting should be safe, well lit, and ventilated. It is preferable that in-depth interview is conducted only after developing rapport with the child. The rapport could be developed by allowing the child to sit where he/she prefers to sit or move; asking about their age, likes, and pet name; and offering toys. It is important to build partnership with parents from the outset, which could be achieved by listening and valuing their opinions, impressions, and efforts and appreciating the parents for the right things they have done.

Depending on the language development and conversational skills, verbal interview can be conducted with simple, structured, clear, and concrete questions. It is better to avoid leading questions. The examination may include the following:

  • Basics: Behaviors suggesting sensory-motor impairments or physical health issues
  • Response to interview situation: Excited, fearful, tense, shy, inhibited, guarded, uncooperative, or defiant
  • Alertness: Overaroused, withdrawn
  • Attachment to parents and response to separation: Clinging, wanting to be carried all the time, indifferent to separation
  • Sociability: Social orientation, approachability, social responsiveness, eye-to-eye contact, reciprocal interactions, and awareness of social boundaries
  • Motor activity level: Fidgetiness, restlessness, hyperactivity, lethargy
  • Course of motor behaviors during interview or response to firm instructions: Quiet initially, but restless later on; unresponsive to firm instructions
  • Impulse control: Snatching, spilling, falling, bumping, climbing, interfering, temper tantrums; aggressive acts such as biting, throwing, beating, pulling hair, slapping
  • Attention and concentration: Goal directedness, task completion, distractibility
  • Speech, language, and communication: Verbal/nonverbal comprehension and expression; vocabulary, articulation, and flow
  • Mood: Inhibited, excessively cheerful, whining and crying, irritable
  • Play behavior: Type of activity, duration, themes, etc.
  • Other inappropriate behaviors: Any excess behaviors that are inappropriate to the age and sociocultural context
  • Impressions on current developmental attainment: Whether excess behaviors or skill deficits are typical of a known psychiatric or developmental disorder?
  • Parent–child interactions: Quality of engagement with child; communication patterns; degree and quality of control over the child; response to good and bad behaviors.


Standardized instruments such as Psychiatric Assessment Schedule for Adults with Developmental Disability, Reiss Screen for Maladaptive Behavior, Psychopathology Inventory for Mentally Retarded Adults, Developmental Behavior Checklist, and Psychiatric Instrument for the Intellectually Disabled Adults can be utilized as per the need. However, rating scales should be used only to complement the clinical observations.


   Laboratory Investigations Top


Often, it is difficult to completely examine children with ID due to their inability to communicate or comprehend commands or due to their behavioral issues. Some of the malformations can be missed in spite of an exhaustive and careful examination. Malformations such as atrial septal defect in early infancy, single kidney, holoprosencephaly, and mild hearing/visual impairment can be missed during routine examination, which can be barriers for adequate management of ID. As highlighted in the earlier sections, an array of etiological factors can result in ID and at least some of them can be potentially treated. Hence, a bunch of investigations are essential not only to identify the cause of ID, but also to make sure the treatable causes have been investigated for [Table 3].
Table 3: Physical investigations in intellectual disability

Click here to view


Majority of Indian families do not possess medical insurance scheme. Hence, clinicians have to carefully consider the financial circumstances of the family, clinical hints, and treatability to order appropriate investigations. One should always consider the possibility of recurrence of the same disorder in the next pregnancy before an investigation is deemed unnecessary. This has to be discussed with the family and appropriate genetic counseling should be provided. Family can then chose to proceed or not to proceed with further investigations. Magnetic resonance imaging of brain and screening of metabolic disorders are considered mandatory investigations in all cases of ID. The American Academy of Pediatrics and American Academy of Neurology provide useful guidelines in this regard (Please refer to Moeschler (2008) and Michelson et al. (2011) for more details).


   Psychosocial Assessments Top


Persons with ID will be at a high risk for neglect and abuse. Therefore, risk assessment should be an integral part of comprehensive assessment plan in ID. Adaptive behavior is always impaired in people with ID, but the deficits are less evident in environments where support systems are in place. Hence, support systems available to the family and child must be reviewed. Therefore, psychosocial assessments are very important.

Assessment of family needs and functioning

Parents and families are the main source to implement the intervention plan in any condition that requires extensive long-term support. Specifically in the context of ID, studies indicate that their perceptions of the condition, disability impact, perceived support, and stress and coping mechanisms are very important moderators of intervention. Therefore, clinicians must consider assessing these areas further. Need may be appropriate tools such as the following could be used for this purpose: Global Entrepreneurship Monitor Questionnaire, Disability Impact Scale, Family Support Scale, Family Efficacy Scale, Family Needs Schedule (note: these scales are available in public domain at www.nimhindia.org/punblications); and Family Interview for Stress and Coping in Mental Retardation for assessing stress and coping of the parents of children with ID.

Psychoeducational assessments

With universalization of elementary education and the Right to Education act, many children with ID are in the mainstream as compared to a decade ago. Children both in the mainstream and in special school settings may need appropriate psychoeducational assessment. Tools such as the Grade Level Assessment Device and Functional Assessment Checklists for Programming (available at www.nimhindia.org/punblications) can be used for this purpose. Another gray area is the assessment of “school readiness skills” because there are no standardized measures. Often, children diagnosed with GDD or young children with ID are referred to mental health professionals for the assessment of school readiness skills. In such a scenario, a clinical assessment could be carried out by focusing on the following: sensory-motor abilities; eye–hand coordination skills; activity-based attention span; receptive and expressive skills (but, not necessarily verbal communication); independent personal care, particularly toilet indication; drinking and eating; sitting tolerance; and basic social skills such as eye contact, waiting for turn, following the authority, staying without primary caregivers, and ability to engage in play. In addition to this, any significant medical history (e.g., seizures, attention-deficit/hyperactivity disorder [ADHD]) which needs supervision of medication in the classroom should also be counted. A special note should be made if any aids and appliances are required to enhance the functional abilities of the child (e.g., reading glasses, hearing aids, wheelchairs, and specially adapted furniture). Accordingly, the assessment report must include appropriate recommendation for placement and intervention.


   Disability Assessment Top


According to the guidelines based on the Rights of Persons with Disabilities Act 2016 (Government of India, 2018, p. 94), disability assessment is done through three stages such as screening, diagnosis, and disability calculation [Table 4]. The minimum age for certification is one completed year. Children above 1 year and up to the age of 5 years shall be given a certificate with a diagnosis of GDD. Children above the age of 5 years shall be given a diagnosis and certificate as ID. The medical superintendent or chief medical officer or civil surgeon or any other equivalent authority as notified by the state government shall be the head of the medical board. The authority shall comprise the following: (a) the medical superintendent or chief medical officer or civil surgeon or any other equivalent authority as notified by the state government; (b) pediatrician or pediatric neurologist (where available)/psychiatrist or physician (if age >18 years); (c) clinical or rehabilitation psychologist; and (d) psychiatrist. It is preferable that clinicians time to time refer to relevant source to be updated with the guidelines. Temporary certificate can be issued for children <5 years, which will be valid for a maximum of 3 or 5 years of age, whichever is earlier. For children aged >5 years, the certificate will mention when to renew. As per the act, the certificate will have to be renewed at the age of 5, 10, and 18 years. The certificate issued at 18 years of age will be valid lifelong.
Table 4: Disability certification process as per the guidelines based on Rights of Persons with Disabilities Act

Click here to view



   Formulating a Treatment Plan Top


The treatment plan needs to address the issues related to the following five dimensions as indicated in a given case (Note: The multiaxial system of comprehensive diagnosis of IDD is taken from NIMHANS evaluation pro forma for IDDs):

  1. Level of intellectual functioning (i.e., severity of ID)
  2. Etiology/syndrome
  3. Associated medical problems
  4. Associated psychiatric problems
  5. Family and psychosocial factors (e.g., awareness, attitude-overprotective, negligent, hostile, favorable; expectations; consistency of parenting; quality of stimulation; stressors in the family, family discard; caregivers' burnout).


Each of these five dimensions will have implications for biological, psychological, and social intervention. Consider, for example, a person with mild ID and ASD and seizures, with limited access to services and health-care facilities in his/her community will have significant impairment in functioning as compared to a person with ID alone. In this example, the former will need appropriate medical, behavioral, and psychosocial interventions to address all these issues.

Setting for intervention is an important factor. Unless there is an indication for careful monitoring of medication on daily basis or poor therapeutic outcome if the patient is anywhere other than in the institutional setting, individuals with ID must be offered services in the community or on day-care basis. The idea is that the persons with ID should be in a least intrusive environment so that they can have maximum opportunities for learning and development in natural environment.

Medical interventions

Every attempt should be made to identify treatable causes of ID or at least potentially treatable symptoms such as hearing impairment and spasticity. Some of the conditions which present with ID are nearly completely preventable or to some extent reversible with appropriate management, provided that it is treated early in the course. Examples of treatable disorders are listed in [Table 5], and such cases have to be referred to specialists accordingly for further management.
Table 5: Summary of medical interventions

Click here to view


It is also important to treat associated medical problems along with therapies aimed at altering the pathophysiology among children with ID. Specialists need to be consulted for appropriate management to obtain maximal benefits. Few examples are treatment of epilepsy with antiepileptic drugs, spasticity with antispasticity medications, hearing impairment with hearing aids and cochlear implantation, sleep problems with sedatives as well as sleep hygiene techniques, and so on.

Genetic counseling

Genetic counseling is often deemed as a specialty in the current medical practice though it can be practiced by all clinicians to varying degrees depending on their expertise. As two-thirds of cases of ID have genetic etiologies, genetic counseling becomes mandatory. The most common situation is when genetic counseling is required in ID is when parents have one child with ID and would like to know the risk of recurrence and possibility of prenatal diagnosis. Genetic counseling not only provides accurate information on the prognosis of disorders and recurrence risks, but also helps in removing guilt and allaying ongoing recrimination in families.

Management of comorbid behavioral and psychiatric disorders

Nearly 20%–80% of the ID population can have problematic behaviors ranging from hyperactivity, temper tantrums, odd behaviors, to aggression. Behavioral problems are potential reasons for stigma, segregation, and caregiver's burden. Lack of occupation and limited developmental opportunities and communication deficits are major factors of problematic behaviors. While problematic behaviors can be a source or trigger for psychiatric problem and/or part of psychiatric disorder, they can also exist independently. In either case, a thorough behavioral plan is required. Identification of the problematic behaviors is the first step in management. Behaviors that lead to social exclusion, stigma, and those that interfere with learning should be given priority. Based on the hierarchy, target behaviors can be selected and functional analysis can be conducted to understand the antecedents and maintaining factors. Basic premise of the behavioral management is that opportunities are created to facilitate positive behaviors that would otherwise serve the same function as the problematic behaviors do (e.g., reinforcing any form of socially appropriate communication as a substitute for temper tantrums secondary to verbal communication deficits). In principle, the techniques should be least intrusive and culturally appropriate; therefore, the behavioral management plan can be implemented through the following three levels:

  1. Restructuring the environment to control the antecedents and provide ample opportunities for positive learning
  2. Differential reinforcement to strengthen the adaptive behaviors by providing opportunities for reinforcement of adaptive behaviors
  3. Controlling inappropriate reinforcement of problematic behaviors.


It is also important to recognize that all problematic behaviors are not due to environmentally mediated, inappropriate reinforcement practices. Problematic behaviors may be an atypical presentation of psychiatric comorbidity or an indicator of the onset of a psychiatric episode. In some cases, problematic behaviors may be a manifestation of ineffective coping strategies to manage the psychiatric distress.

Psychiatric comorbidity not only presents itself more diffusely and atypically in these children, but also it is often difficult to treat. Carefully studying behavioral profile may point to a particular psychiatric disorder. Management may need a multipronged approach usually involving pharmacological and psychosocial interventions. If there is inadequate information to establish a psychiatric diagnosis, psychosocial interventions should be attempted first.

As only a handful of medications have been licensed for use in children, often, it is difficult to manage these disorders. This has to be discussed with parents in detail and their expectations should be handled regarding the outcome of such a treatment. Very few large systematic controlled trials are available in ID group; however, open drug trials, case reports, and expert reviews suggest the following:

  • Begin with low dosage and increase it slowly
  • Adequate trial time should be allowed before deeming failure of a medication
  • Outcome to be monitored at multiple settings (home, school)
  • Rationalize medications when multiple medications are being used and change one drug at a time
  • Pediatric dosing schedules and guideline should be followed.


There are few studies on medications in comorbid disorders in ID, namely, methylphenidate in ADHD, or antipsychotics for schizophrenia. Risperidone also is widely studied as symptomatic treatment for problematic behaviors such as stereotypes and aggression [Table 6]. For further details in dosing and indications, the latest edition of the Maudsley Prescribing Guidelines are a good source. Specific details on pharmacological management could also found in condition-specific clinical practice guidelines of the Indian Psychiatric Society.
Table 6: Summary of pharmacological treatment options

Click here to view


Nonpharmacological management

Child-centric interventions

Nonpharmacological interventions should be guided by life span and functional approaches. Accordingly, the following general framework can be adapted in regular clinical practice:

  • Life span approach: Life span approach is that it regards the developmental needs and the tasks that the individual must achieve at each developmental stage to adapt to the environment. Accordingly, the skill training focuses on all important domains of adaptive behaviors such as conceptual, social, and practical skills that are considered important at a given developmental stage. In the initial 3 years, the focus should be on acquiring sensory-motor skills, socio-communication skills, basic self-help skills, and concepts. During 3–6 years of age, the focus can be on school readiness skills and mastery of culturally appropriate adaptive behaviors. During 6–18 years of age, the focus should be on the consolidation of academic and independent personal skills that can lead to future vocational training, employment, and adult independent living
  • Functional approach: It is preferable that the tasks taught to the individual enable him or her to function well in day-to-day tasks. For example, there is no functional utility of mastering the spelling of five exotic animals as compared to mastering the sight words essential for daily functioning and community use (e.g., danger, exit, stop, price, and own name). Irrespective of the age and sociocultural context, each individual first needs training in self-care (toilet control, bathing, eating, dressing, and grooming), motor skills (especially, eye–hand coordination skills), receptive and expressive language abilities, social skills, and concepts in one set. Later, the children can be recommended for academics or functional academics, finally leading to vocational training, gainful occupation, and independent living skills. Throughout the program, health and safety skills should be strengthened.
  • Making provisions for additional disabilities: Depending on additional disabilities, the child may need aids and appliances and appropriate therapeutic interventions. For example, adapted furniture in cerebral palsy and hearing aids for hearing impairment
  • Special focus on early intervention: Early identification and intervention with children at risk for GDD or ID should be a top priority. It is also important to recognize that early intervention can start from prenatal period in terms of identifying high-risk pregnancies, providing appropriate health care, and dealing with psychosocial adversities. Nonetheless, the postnatal early intervention plan should include accurate diagnosis of ID and comorbid conditions; identification of underlying etiological processes and methods of treatment as applicable; and activities to facilitate sensory-motor integration, speech and language development, and socioemotional development. The basis of early intervention is healthy bonding and attachment between mother and the child. Therefore, any stable caregiver can also be involved in early stimulation. In principle, early intervention programs should aim at stabilizing the current developmental milestones and create opportunities for the development of future tasks. Play-based methods and culturally rooted good practices of early child care should be strengthened. Materials recommended for intervention should be easily available and culturally appropriate; otherwise, parents will be overwhelmed if they are not easily available. For more formal intervention, referrals can be to the District Early Intervention Centers of the Rashtriya Bal Swasthya Karyakram (RBSK) and the Anganwadi Centers of the Integrated Child Development Services (ICDS)
  • Referral and linkage: Appropriate services can be obtained from programs under the Sarva Shiksha Abhiyan, National Institute of Open Schooling, District Disability Rehabilitation Centers, Composite Rehabilitation Centers, national institutes, and local nongovernment agencies (more details of the government schemes can be found at www.socialjustice.nic.in). Wherever possible, it is better to refer the individual to the agencies in their own locality to cut down the costs of rehabilitation. Therefore, a registry of local, regional, and national agencies working in the area of developmental disabilities can be maintained for this purpose.


Family-centered interventions

  • Parents and families should be given proper information regarding the nature, needs, and management of ID and its comorbidities in simple language devoid of any technical terms. Need may be appropriate literature, and specific web-based sources can be recommended for further reading. Siblings and other key family members can also be involved in the program plan.
  • Parents and families should be supported in finding right resources for health care, therapy, education, and vocational and occupational needs.
  • Ensure that parents and families are aware of the social provisions and importance of disability certificate for the child to avail the same.
  • Emphasize on self-advocacy by creating awareness about various policies and provisions related to ID. If the person with ID is an adult, information regarding the guardianship and National Trust Act must be compulsorily provided
  • Making meaning of the condition and developing a sense of control are crucial for optimum functioning of families. Various methods such as individual counseling, group counseling, parent training programs, and self-help groups can be used to achieve this.
  • Each family is unique therefore the family support programmes must be individualized to meet the needs of the family in the context of care-giving and disability impact.
  • Parents and primary caregivers must be routinely screened for stress-related disorders because there is ample evidence to suggest that syndromal depression and anxiety are high among parents of children with ID.


In summary, ID is a developmental disorder that affects general intellectual functioning and adaptive behaviors. It has no definite cause, but has multiple risk factors including genetic, biological, and environmental factors. Depending on the severity of the condition and the underlying etiological processes, ID can also present with comorbid conditions. It is important to identify the treatable conditions and treat the same. Special attention should be paid to psychiatric and behavioral disorders, which are common in ID and cause stigma, caregiver burden, and need for medication and segregation. Since ID causes disability, appropriate measures should be taken to certify disability and guide the families for appropriate support systems including the social benefits.

Nonpharmacological intervention should focus on skill development leading to educational and vocational competencies so that the individual will acquire necessary capacities for future adult independent living. Depending on the stage of development, referral can be made to different service agencies starting from early intervention services under the RBSK and ICDS to educational provisions under the Sarva Shiksha Abhiyan to vocational training and guardianship under the National Trust Act. Parents and families should be involved along with the individual at all levels of decision-making in order to promote self-advocacy.[57]

Acknowledgment

We gratefully acknowledge the Clinical Practice Guidelines on Mental Retardation (2008) by Dr. Satish C. Girimaji for the Indian Psychiatric Society that served as a good source for this article.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.  Back to cited text no. 1
    
2.
Bertelli M, Scuticchio D, Ferrandi A, Lassi S, Mango F, Ciavatta C, et al. Reliability and validity of the SPAID-G checklist for detecting psychiatric disorders in adults with intellectual disability. Res Dev Disabil 2012;33:382-90.  Back to cited text no. 2
    
3.
Borthwick-Duffy SA. Epidemiology and prevalence of psychopathology in people with mental retardation. J Consult Clin Psychol 1994;62:17-27.  Back to cited text no. 3
    
4.
Choudhury P, Girimaji S, Srinath S, Seshadri SP. An open trial of clonidine for hyperkinesis in children with mental retardation and epilepsy. Indian J Psychol Med 1993;16:41-4.  Back to cited text no. 4
    
5.
Coughlin CR 2nd, Scharer GH, Shaikh TH. Clinical impact of copy number variation analysis using high-resolution microarray technologies: Advantages, limitations and concerns. Genome Med 2012;4:80.  Back to cited text no. 5
    
6.
Cunningham C. Training and education approaches for parents of children with special needs. Br J Med Psychol 1985;58(Pt 3):285-305.  Back to cited text no. 6
    
7.
Dykens EM, Hodapp RM. Three steps toward improving the measurement of behavior in behavioral phenotype research. Child Adolesc Psychiatr Clin N Am 2007;16:617-30.  Back to cited text no. 7
    
8.
Einfeld SL, Tonge BJ. Population prevalence of psychopathology in children and adolescents with intellectual disability: II. Epidemiological findings. J Intellect Disabil Res 1996;40(Pt 2):99-109.  Back to cited text no. 8
    
9.
Einfeld SL, Tonge BJ. The developmental behavior checklist: The development and validation of an instrument to assess behavioral and emotional disturbance in children and adolescents with mental retardation. J Autism Dev Disord 1995;25:81-104.  Back to cited text no. 9
    
10.
Flynn JR. IQ gains and Binet decrements. J Educ Meas 1984;21:283-90.  Back to cited text no. 10
    
11.
Gilissen C, Hehir-Kwa JY, Thung DT, van de Vorst M, van Bon BW, Willemsen MH, et al. Genome sequencing identifies major causes of severe intellectual disability. Nature 2014;511:344-7.  Back to cited text no. 11
    
12.
Girimaji SC, Srinath S, Seshadri S, Krishna DK. Family interview for stress and coping in mental retardation (fisc-mr): A tool to study stress and coping in families of children with mental retardation. Indian J Psychiatry 1999;41:341-9.  Back to cited text no. 12
[PUBMED]  [Full text]  
13.
Girimaji SC, Srinath S. Perspectives of intellectual disability in India: Epidemiology, policy, services for children and adults. Curr Opin Psychiatry 2010;23:441-6.  Back to cited text no. 13
    
14.
Girimaji SC. Clinical practice guidelines for the diagnosis and management of children with mental retardation. Indian Psychiatric Society Clinical Practice Guidelines, 2008;43-67. Available from: http://www.indianjpsychiatry.org/cpg/cpg2008/CPG-CAP_05.pdf. [Last accessed on 2018 Jun 06].  Back to cited text no. 14
    
15.
Girimaji SC. Comorbidity of mental retardation and affective disorders. J Indian Med Assoc 2000;98:245, 248-9.  Back to cited text no. 15
    
16.
Girimaji SC. Final Report of the Project 'Evaluation of the Effectiveness of Brief in-Patient Family Intervention Versus Outpatient Intervention for Mentally Retarded Children. New Delhi: Indian Council of Medical Research; 1996.  Back to cited text no. 16
    
17.
Handen BL, Gilchrist R. Practitioner review: Psychopharmacology in children and adolescents with mental retardation. J Child Psychol Psychiatry 2006;47:871-82.  Back to cited text no. 17
    
18.
Honeycutt AA, Grosse SD, Dunlap LJ, Schendel DE, Chen H, Brann E, et al. Economic costs of mental retardation, cerebral palsy, hearing loss, and vision impairment. In Altman BM, Barnartt SN, Hendershot GE, Larson SA. (eds.), Using survey data to study disability: Results from the National Health Survey on Disability. Research in Social Science and Disability, Vol. 3. London: Emerald Group Publishing; 2003. p. 207-28.  Back to cited text no. 18
    
19.
Jones KL, Jones MC, Campo MD. Smith's Recognizable Patterns of Human Malformation. 6th ed. Philadelphia: Elsevier Saunders; 2006.  Back to cited text no. 19
    
20.
Khess CR, Dutta I, Chakrabarty I, Bhattacharya P, Das J, Kothari S, et al. Comorbidity in children with mental retardation. Indian J Psychiatry 1998;40:289-94.  Back to cited text no. 20
[PUBMED]  [Full text]  
21.
Kishore MT, Nizamie A, Nizamie SH, Jahan M. Psychiatric diagnosis in persons with intellectual disability in India. J Intellect Disabil Res 2004;48:19-24.  Back to cited text no. 21
    
22.
Kishore MT, Nizamie SH, Nizamie A. The behavioural profile of psychiatric disorders in persons with intellectual disability. J Intellect Disabil Res 2005; 49; 852-7.  Back to cited text no. 22
    
23.
Kishore MT. Disability impact and coping in mothers of children with intellectual disabilities and multiple disabilities. J Intellect Disabil 2011;15:241-51.  Back to cited text no. 23
    
24.
Kishore MT. Trends in Intelligence Testing of Persons with Mental Retardation and its Implication for Certification of Disability and Service Provisions. An unpublished Study Funded by the Indian Council of Social Sciences Research; 2011.  Back to cited text no. 24
    
25.
Lee H, Deignan JL, Dorrani N, Strom SP, Kantarci S, Quintero-Rivera F, et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA 2014;312:1880-7.  Back to cited text no. 25
    
26.
Makela NL, Birch PH, Friedman JM, Marra CA. Parental perceived value of a diagnosis for intellectual disability (ID): A qualitative comparison of families with and without a diagnosis for their child's ID. Am J Med Genet A 2009;149A: 2393-402.  Back to cited text no. 26
    
27.
Mandal K, Boggula VR, Borkar M, Agarwal S, Phadke SR. Use of multiplex ligation-dependent probe amplification (MLPA) in screening of subtelomeric regions in children with idiopathic mental retardation. Indian J Pediatr 2009;76:1027-31.  Back to cited text no. 27
    
28.
McLaren J, Bryson SE. Review of recent epidemiological studies of mental retardation: Prevalence, associated disorders, and etiology. Am J Ment Retard 1987;92:243-54.  Back to cited text no. 28
    
29.
Michelson DJ, Shevell MI, Sherr EH, Moeschler JB, Gropman AL, Ashwal S, et al. Evidence report: Genetic and metabolic testing on children with global developmental delay: Report of the quality standards subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2011;77:1629-35.  Back to cited text no. 29
    
30.
Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, et al. Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010;86:749-64.  Back to cited text no. 30
    
31.
Modell B, Darr A. Science and society: Genetic counselling and customary consanguineous marriage. Nat Rev Genet 2002;3:225-9.  Back to cited text no. 31
    
32.
Moeschler JB, Shevell M; American Academy of Pediatrics Committee on Genetics. Clinical genetic evaluation of the child with mental retardation or developmental delays. Pediatrics 2006;117:2304-16.  Back to cited text no. 32
    
33.
Moeschler JB. Medical genetics diagnostic evaluation of the child with global developmental delay or intellectual disability. Curr Opin Neurol 2008;21:117-22.  Back to cited text no. 33
    
34.
Musante L, Ropers HH. Genetics of recessive cognitive disorders. Trends Genet 2014;30:32-9.  Back to cited text no. 34
    
35.
Narayanan HS, Girimaji SR, Gandhi DH, Raju KM, Rao PM, Nardev G, et al. Brief in-patient family intervention in mental retardation. Indian J Psychiatry 1988;30:275-81.  Back to cited text no. 35
[PUBMED]  [Full text]  
36.
Reiss S, Levitan GW, Szyszko J. Emotional disturbance and mental retardation: Diagnostic overshadowing. Am J Ment Defic 1982;86:567-74.  Back to cited text no. 36
    
37.
Reiss S, Havercamp SM. The Reiss Screen for Maladaptive Behavior Test Manual. Worthington, OH: IDS Publishing Corp; 1997.  Back to cited text no. 37
    
38.
Riddle MA, Walkup JT, Vitiello B. Introduction: Issues and viewpoints in pediatric psychopharmacology. Int Rev Psychiatry 2008;20:119-20.  Back to cited text no. 38
    
39.
Riou EM, Ghosh S, Francoeur E, Shevell MI. Global developmental delay and its relationship to cognitive skills. Dev Med Child Neurol 2009;51:600-6.  Back to cited text no. 39
    
40.
Russell PS, al John JK, Lakshmanan JL. Family intervention for intellectually disabled children. Randomised controlled trial. Br J Psychiatry 1999;174:254-8.  Back to cited text no. 40
    
41.
Salvador-Carulla L, Reed GM, Vaez-Azizi LM, Cooper SA, Martinez-Leal R, Bertelli M, et al. Intellectual developmental disorders: Towards a new name, definition and framework for “mental retardation/intellectual disability” in ICD-11. World Psychiatry 2011;10:175-80.  Back to cited text no. 41
    
42.
Salvador-Carulla L, Garcia-Gutierrez C. The WHO construct of health-related functioning (HrF) and its implications for health policy. BMC Public Health 2011;11 Suppl 4:S9.  Back to cited text no. 42
    
43.
Santosh PJ, Baird G. Psychopharmacotherapy in children and adults with intellectual disability. Lancet 1999;354:233-42.  Back to cited text no. 43
    
44.
Schalock RL, Borthwick-Duffy SA, Bradley VJ, Buntinx WH, Coulter DL, Craig EM, et al. Intellectual Disability: Definition, Classification, and Systems of Supports, 11th ed. Washington, DC: American Association on Intellectual and Developmental Disabilities; 2010.  Back to cited text no. 44
    
45.
Senatore V, Matson JL, Kazdin AE. An inventory to assess psychopathology of mentally retarded adults. Am J Ment Defic 1985;89:459-66.  Back to cited text no. 45
    
46.
Shevell M, Ashwal S, Donley D, Flint J, Gingold M, Hirtz D, et al. Practice parameter: Evaluation of the child with global developmental delay: Report of the quality standards subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2003;60:367-80.  Back to cited text no. 46
    
47.
Shivakumar PT. Prevalence and Patterns of Psychiatric Comorbidity in Children and Adolescents Attending Mental Retardation Clinic. MD Thesis Submitted to NIMHANS, Bangalore; 2004.  Back to cited text no. 47
    
48.
Sovner R. Limiting factors in the use of DSM-III criteria with mentally ill/mentally retarded persons. Psychopharmacol Bull 1986;22:1055-9.  Back to cited text no. 48
    
49.
Taylor D, Paton C, Kapur S. The Maudsley Prescribing Guidelines in Psychiatry. New Jersey: Wiley Blackwell; 2018.  Back to cited text no. 49
    
50.
Trahan LH, Stuebing KK, Fletcher JM, Hiscock M. The Flynn effect: A meta-analysis. Psychol Bull 2014;140:1332-60.  Back to cited text no. 50
    
51.
Turner TH. Schizophrenia and mental handicap: An historical review, with implications for further research. Psychol Med 1989;19:301-14.  Back to cited text no. 51
    
52.
van Karnebeek CD, Stockler S. Treatable inborn errors of metabolism causing intellectual disability: A systematic literature review. Mol Genet Metab 2012;105:368-81.  Back to cited text no. 52
    
53.
van Karnebeek CD, Jansweijer MC, Leenders AG, Offringa M, Hennekam RC. Diagnostic investigations in individuals with mental retardation: A systematic literature review of their usefulness. Eur J Hum Genet 2005;13:6-25.  Back to cited text no. 53
    
54.
Verma IC, Ahluwalia TP, Saxena BN. Genetic Counselling and Antenatal Diagnosis of Common Genetic Disorders. Report of the ICMR Task Force Study. New Delhi: ICMR; 1996.  Back to cited text no. 54
    
55.
Verma IC, Saxena R, Lall M, Bijarnia S, Sharma R. Genetic counselling and prenatal diagnosis in India-experiences at Sir Ganga Ram Hospital. Indian J Pediatr 2003;70:293-7.  Back to cited text no. 55
    
56.
Volkmar F, Dykens E. Mental retardation. In: Rutter M, Taylor J, editors. Child and Adolescent Psychiatry. 4th ed., Vol. 4. Oxford: Blackwell Science; 2002. p. 697-710.  Back to cited text no. 56
    
57.
Wilska ML, Kaski MK. Why and how to assess the aetiological diagnosis of children with intellectual disability/mental retardation and other neurodevelopmental disorders: Description of the Finnish approach. Eur J Paediatr Neurol 2001;5:7-13.  Back to cited text no. 57
    

Top
Correspondence Address:
Prof. Shekhar P Seshadri
National Institute of Mental Health and Neurosciences, Bengaluru - 560 029, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/psychiatry.IndianJPsychiatry_507_18

Rights and Permissions


    Figures

  [Figure 1]
 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6]



 

Top